Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

polarean (POLX) Regulatory News

Date Source Headline
9th Aug 2019 4:14 pm RNS Statement on Amphion Innovations
5th Aug 2019 7:00 am RNS Phase III Clinical Trials update
31st Jul 2019 10:04 am RNS Total Voting Rights
30th Jul 2019 3:18 pm RNS Holding(s) in Company
30th Jul 2019 2:25 pm RNS Holding(s) in Company
29th Jul 2019 5:31 pm RNS Holding(s) in Company
25th Jul 2019 3:31 pm RNS Result of AGM
24th Jul 2019 2:45 pm RNS Exercise of Warrants
22nd Jul 2019 10:00 am RNS Placing to raise £2.1 million
11th Jul 2019 7:00 am RNS New System Order
27th Jun 2019 7:00 am RNS Final Results
13th Jun 2019 5:02 pm RNS Investor Symposium presentations available online
11th Jun 2019 7:00 am RNS Phase III Clinical Trials - Update
5th Jun 2019 7:00 am RNS New System Order
23rd May 2019 3:26 pm RNS Grant of Share Options
23rd May 2019 7:00 am RNS London Investor Symposium
21st May 2019 7:00 am RNS 3rd tranche of $3m pediatric study grant confirmed
13th May 2019 7:00 am RNS Clinical trial update
30th Apr 2019 7:00 am RNS Total Voting Rights
29th Apr 2019 7:00 am RNS Appointment of Chief Financial Officer
2nd Apr 2019 7:00 am RNS Exercise of Warrants
1st Apr 2019 7:00 am RNS Amphion Innovations - Pledge of Polarean shares
15th Feb 2019 7:00 am RNS New System Order
24th Jan 2019 7:00 am RNS Appointment of Nominated Adviser and Broker
21st Jan 2019 3:36 pm RNS Holding(s) in Company
3rd Jan 2019 7:00 am RNS Holding(s) in Company
28th Dec 2018 2:52 pm RNS Result of General Meeting and Total Voting Rights
11th Dec 2018 7:05 am RNS Investment in Polarean & Loan Facility Repayment
11th Dec 2018 7:00 am RNS Conditional Fundraise to raise US$4 million
13th Nov 2018 7:00 am RNS Licencing Agreement with Duke University
6th Nov 2018 7:00 am RNS Company update
5th Nov 2018 7:00 am RNS Nominated Adviser Status
3rd Oct 2018 7:00 am RNS Delivery of Xenon Polariser
23rd Aug 2018 7:00 am RNS FIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22nd Aug 2018 7:00 am RNS Half-year Report
27th Jul 2018 7:00 am RNS Company update
18th Jul 2018 2:28 pm RNS Result of AGM
17th Jul 2018 2:49 pm RNS Holding(s) in Company
10th Jul 2018 3:22 pm RNS Result of Placing
9th Jul 2018 2:41 pm RNS Proposed Placing to raise a minimum of £0.78m
FTSE 100 Latest
Value8,774.65
Change-17.15